Skip to content

In the BioHarmony Drug Report Database

Stiripentol

Diacomit (stiripentol) is a small molecule pharmaceutical. Stiripentol was first approved as Diacomit on 2007-01-03. It is used to treat seizures in the USA. It has been approved in Europe to treat juvenile myoclonic epilepsy.
Trade Name Diacomit
Common Name Stiripentol
Indication juvenile myoclonic epilepsy, seizures
Drug Class
Stiripentol
Get full access now